Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
152.77
-0.04 (-0.03%)
At close: Feb 4, 2026
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $295.04 billion as of February 6, 2026. Its market cap has increased by 49.76% in one year.
Market Cap
295.04B
Enterprise Value
319.92B
Revenue
56.67B
Ranking
n/a
PE Ratio
21.10
Stock Price
$152.77
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 295.04B, an increase of 131.68%. That is a compound annual growth rate of 3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 295.04B | 10.92% |
| Dec 30, 2025 | 266.00B | 36.05% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 805.86M |
| Glass House Brands | 733.17M |
| Elite Pharmaceuticals | 481.05M |
| Northwest Biotherapeutics | 406.55M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| CytoDyn | 317.38M |
| OpGen | 292.16M |